Feb 25,2021

January AI Raises $21 Million to Fuel Growth of Its Breakthrough Diabetes Management Technology

Health tech startup combines real-time glucose monitoring and personalized machine learning to accurately track and predict the effects of diet, exercise, and sleep on health

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
Mar 22,2021

Bigfoot Biomedical Secures up to $57 Million in Combined Debt and Equity Financing From Madryn Asset Management

Bigfoot Biomedical, a company dedicated to better health outcomes for people with insulin-requiring diabetes, announced that it has secured new financing of up to $57 million from Madryn Asset Management LP, an alternative asset management firm focused on investments in innovative health care companies.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Apr 19,2021

Diabetes Reversal Leader Virta Health Raises $133M Series E to Take Type 2 Diabetes Reversal Mainstream

Led by Tiger Global, the financing values Virta at $2 billion and signals a shift in type 2 diabetes care toward long-term disease reversal powered by next-generation telehealth

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Apr 21,2021

Fitterfly raises $3.1 million in funding round led by Fireside Ventures

Fireside Ventures, which is making its first healthtech bet in Fitterfly, will get a significant stake as well as a board seat for Managing Partner Kanwaljit Singh in the two-year-old startup. Read more at: https://economictimes.indiatimes.com/tech/funding/fitterfly-raises-3-1-million-in-funding-round-led-by-fireside-ventures/articleshow/82162628.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 28,2021

my mhealth and collaborators awarded €2.5M Eurostars Grant for better heart health project

Immersive cardiac rehabilitation app, myHeart uses behavioural feedback and gamification features to improve patient well-being.

FUNDING GRANT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 19,2021

Sweetch Secures $20 Million Series A to Accelerate Fully Automated Hyper-Personalized Engagement Between Health Ecosystem Players and People With Chronic Conditions

Sweetch, a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, announced the completion of a $20 million Series A round of funding. The funds will be directed toward the company’s continued global expansion and further development of its artificial intelligence (AI) and emotional intelligence (EI) behavioral science technology that engages individuals to achieve their health goals with the right message in the right tone, time and real-world context.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Aug 04,2021

DayTwo Announces New CEO and Raises $37 Million For Expansion of Chronic Disease Solutions

David Henderson, former founding executive member of Oscar Health, has been appointed as Chief Executive Officer of DayTwo. He joins to further scale the company and expand solutions for employers, health plans, and health systems. DayTwo also announced $37 million in new funding to accelerate its expansion of chronic disease interventions.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Aug 16,2021

Ultrahuman raises $17.5M, touting a wearable blood glucose tracker

Fitness platform using glucose biomarkers, Ultrahuman, has officially announced a $17.5 million Series B fundraise, with investment coming from early stage fund Alpha Wave Incubation, Steadview Capital, Nexus Venture Partners, Blume Ventures and Utsav Somani’s iSeed fund.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Sep 07,2021

Indigo Diabetes Receives €3 million Hephaestus Research Grant to Support Development of CMM Technology

Indigo Diabetes N.V., a pioneering developer of medical solutions using nanophotonics, is pleased to announce that it has received a €3 million grant from VLAIO, the Flanders organisation for Innovation & Entrepreneurship, to conduct research into high volume production of its next-generation continuous multi-metabolite (CMM) technology.

FUNDING
View Analyst & Ambassador Comments
Go to original news
Sep 20,2021

9am Health launches with $3.7M to tackle virtual diabetes care

San Diego-based company announced a $3.7 million seed round from Founders Fund, Define Ventures, Speedinvest and iSeed Ventures to target the 1 in 3 people living with diabetes in the United States, Westermann told TechCrunch.

FUNDING SEED ROUND

#telehealth

View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING